New imaging agent may reveal hidden brain tumor cells after surgery
NCT ID NCT05554302
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a special PET scan using an investigational agent called 18F-Fluciclovine can find leftover tumor tissue after brain metastasis surgery better than standard MRI. About 20 adults who have had brain tumor surgery and are scheduled for radiation will get an optional PET scan. The goal is to see if this scan helps doctors plan more precise radiation and predict if the tumor might come back.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BRAIN CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Miami Cancer Institute at Baptist Health South Florida
RECRUITINGMiami, Florida, 33176, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a simple dye help surgeons see brain tumors in real time?
- Can a 3D camera make brain radiation safer and more precise?
- Mapping the hidden toll of brain radiation on young minds
- Pinpoint radiation may spare the brain in lung cancer that spreads
- Could an ALS drug clear the fog of chemo brain?
- Spinal fluid DNA test could personalize brain cancer therapy